 Kentaro Yomogida
Concepts (424)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 14 | 2023 | 1631 | 1.350 |
Why?
| | Spermatogenesis | 19 | 2013 | 62 | 1.100 |
Why?
| | Muscles | 2 | 2024 | 323 | 0.980 |
Why?
| | Testis | 28 | 2008 | 144 | 0.970 |
Why?
| | Sertoli Cells | 8 | 2004 | 23 | 0.890 |
Why?
| | Ice | 1 | 2024 | 19 | 0.890 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2023 | 14 | 0.870 |
Why?
| | T-Box Domain Proteins | 2 | 2021 | 96 | 0.770 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 85 | 0.750 |
Why?
| | Perciformes | 1 | 2020 | 17 | 0.680 |
Why?
| | Immunity, Cellular | 1 | 2021 | 267 | 0.660 |
Why?
| | Cryopreservation | 1 | 2020 | 98 | 0.640 |
Why?
| | Immunity, Innate | 2 | 2021 | 803 | 0.600 |
Why?
| | Interleukin-17 | 2 | 2014 | 107 | 0.510 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 76 | 0.490 |
Why?
| | Mice | 48 | 2024 | 16579 | 0.470 |
Why?
| | DNA-Binding Proteins | 12 | 2008 | 1415 | 0.450 |
Why?
| | Superantigens | 1 | 2013 | 70 | 0.420 |
Why?
| | Th1 Cells | 1 | 2013 | 136 | 0.400 |
Why?
| | Magnetic Fields | 2 | 2024 | 22 | 0.400 |
Why?
| | Streptavidin | 1 | 2012 | 14 | 0.390 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 179 | 0.390 |
Why?
| | Cell Polarity | 1 | 2013 | 140 | 0.390 |
Why?
| | Freezing | 2 | 2024 | 86 | 0.390 |
Why?
| | Animals | 53 | 2024 | 34501 | 0.370 |
Why?
| | Arthritis, Experimental | 1 | 2013 | 128 | 0.370 |
Why?
| | Interferon-gamma | 3 | 2021 | 761 | 0.360 |
Why?
| | Interleukin-2 | 1 | 2012 | 430 | 0.350 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 374 | 0.340 |
Why?
| | Transfection | 9 | 2014 | 895 | 0.310 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1098 | 0.290 |
Why?
| | Infertility, Male | 4 | 2013 | 61 | 0.280 |
Why?
| | Intestinal Mucosa | 2 | 2023 | 575 | 0.270 |
Why?
| | Germ Cells | 8 | 2004 | 59 | 0.260 |
Why?
| | Spermatogonia | 7 | 2008 | 11 | 0.260 |
Why?
| | Mice, Inbred C57BL | 19 | 2023 | 5257 | 0.260 |
Why?
| | Nerve Growth Factors | 2 | 2003 | 73 | 0.260 |
Why?
| | Electroporation | 2 | 2003 | 37 | 0.250 |
Why?
| | Spermatozoa | 8 | 2006 | 91 | 0.240 |
Why?
| | Gene Expression Regulation | 8 | 2021 | 2506 | 0.240 |
Why?
| | CD8 Antigens | 1 | 2023 | 75 | 0.220 |
Why?
| | Base Sequence | 23 | 2006 | 2134 | 0.220 |
Why?
| | Crystallization | 1 | 2024 | 137 | 0.220 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1922 | 0.220 |
Why?
| | Interleukin-15 | 1 | 2023 | 82 | 0.210 |
Why?
| | RNA, Messenger | 20 | 2011 | 2674 | 0.210 |
Why?
| | Mice, Knockout | 7 | 2023 | 2752 | 0.200 |
Why?
| | Haploidy | 8 | 2003 | 24 | 0.200 |
Why?
| | Membrane Proteins | 3 | 2021 | 1108 | 0.200 |
Why?
| | Zinc Fingers | 4 | 2000 | 43 | 0.200 |
Why?
| | Neuroglia | 1 | 2003 | 166 | 0.200 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2021 | 7 | 0.190 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 51 | 0.190 |
Why?
| | Gene Expression | 7 | 2003 | 1462 | 0.190 |
Why?
| | Granzymes | 1 | 2021 | 46 | 0.190 |
Why?
| | Cell Nucleus | 7 | 2005 | 579 | 0.190 |
Why?
| | Cell Differentiation | 13 | 2019 | 1883 | 0.180 |
Why?
| | Spermatids | 7 | 2013 | 20 | 0.180 |
Why?
| | Molecular Sequence Data | 21 | 2005 | 2818 | 0.180 |
Why?
| | Liver | 3 | 2021 | 1827 | 0.170 |
Why?
| | Gene Deletion | 1 | 2021 | 372 | 0.170 |
Why?
| | Receptors, Cell Surface | 1 | 2022 | 371 | 0.170 |
Why?
| | Green Fluorescent Proteins | 9 | 2005 | 382 | 0.170 |
Why?
| | DNA, Complementary | 8 | 2005 | 267 | 0.160 |
Why?
| | Eosinophils | 1 | 2022 | 323 | 0.160 |
Why?
| | Transcription, Genetic | 13 | 2008 | 1398 | 0.160 |
Why?
| | Palatine Tonsil | 1 | 2019 | 44 | 0.160 |
Why?
| | Antigens, CD | 1 | 2021 | 479 | 0.160 |
Why?
| | Myxoma | 1 | 2018 | 12 | 0.160 |
Why?
| | Heart Neoplasms | 1 | 2018 | 49 | 0.150 |
Why?
| | Luminescent Proteins | 7 | 2003 | 176 | 0.150 |
Why?
| | Heart Atria | 1 | 2018 | 124 | 0.150 |
Why?
| | Proteins | 5 | 2005 | 936 | 0.150 |
Why?
| | Cell Line | 9 | 2014 | 2731 | 0.150 |
Why?
| | Seminiferous Tubules | 6 | 2008 | 12 | 0.140 |
Why?
| | 5-Aminolevulinate Synthetase | 2 | 1997 | 2 | 0.140 |
Why?
| | Interleukins | 1 | 2019 | 242 | 0.140 |
Why?
| | Amino Acid Sequence | 16 | 2005 | 2041 | 0.140 |
Why?
| | Lymphocytes | 1 | 2019 | 366 | 0.140 |
Why?
| | Stem Cells | 5 | 2002 | 578 | 0.140 |
Why?
| | Cloning, Molecular | 10 | 2005 | 522 | 0.140 |
Why?
| | Mice, Mutant Strains | 3 | 2003 | 292 | 0.130 |
Why?
| | Promoter Regions, Genetic | 8 | 2011 | 1199 | 0.130 |
Why?
| | Proto-Oncogene Proteins | 3 | 2008 | 634 | 0.130 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 141 | 0.120 |
Why?
| | Blotting, Northern | 11 | 2003 | 199 | 0.120 |
Why?
| | Immunohistochemistry | 10 | 2013 | 1669 | 0.120 |
Why?
| | Male | 45 | 2013 | 62883 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2013 | 2335 | 0.120 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2014 | 12 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 4 | 2013 | 632 | 0.120 |
Why?
| | CD4 Antigens | 1 | 2014 | 137 | 0.110 |
Why?
| | Cell Division | 5 | 2003 | 779 | 0.110 |
Why?
| | Exons | 9 | 2011 | 337 | 0.110 |
Why?
| | Th17 Cells | 1 | 2014 | 82 | 0.110 |
Why?
| | Monomeric Clathrin Assembly Proteins | 1 | 2013 | 5 | 0.110 |
Why?
| | Acrosome | 1 | 2013 | 5 | 0.110 |
Why?
| | trans-Golgi Network | 1 | 2013 | 13 | 0.110 |
Why?
| | Zymosan | 1 | 2013 | 65 | 0.110 |
Why?
| | Carbolines | 1 | 2013 | 27 | 0.100 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2013 | 36 | 0.100 |
Why?
| | Stem Cell Factor | 3 | 2002 | 15 | 0.100 |
Why?
| | Cell Membrane Permeability | 1 | 2013 | 80 | 0.100 |
Why?
| | Protein Transport | 2 | 2013 | 422 | 0.100 |
Why?
| | Microcirculation | 1 | 2013 | 137 | 0.100 |
Why?
| | Biomarkers | 3 | 2021 | 3881 | 0.100 |
Why?
| | Culture Media | 1 | 2013 | 167 | 0.100 |
Why?
| | Genes, Bacterial | 1 | 1993 | 158 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 571 | 0.100 |
Why?
| | Quality Improvement | 1 | 2020 | 1100 | 0.100 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 359 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2013 | 334 | 0.090 |
Why?
| | Nuclear Proteins | 3 | 2003 | 648 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 326 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2008 | 815 | 0.090 |
Why?
| | Spleen | 1 | 2013 | 513 | 0.090 |
Why?
| | Meiosis | 2 | 2003 | 63 | 0.090 |
Why?
| | Gene Library | 8 | 2003 | 116 | 0.090 |
Why?
| | Autophagy | 1 | 2013 | 266 | 0.090 |
Why?
| | Actins | 2 | 2003 | 401 | 0.090 |
Why?
| | Lymph Nodes | 1 | 2013 | 467 | 0.090 |
Why?
| | In Situ Hybridization | 8 | 2004 | 292 | 0.090 |
Why?
| | Histones | 3 | 2006 | 581 | 0.090 |
Why?
| | Cytoplasm | 4 | 2005 | 258 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 500 | 0.080 |
Why?
| | Heat-Shock Proteins | 3 | 2006 | 131 | 0.080 |
Why?
| | Estrogen Receptor alpha | 1 | 2011 | 134 | 0.080 |
Why?
| | Cell Membrane | 1 | 2013 | 722 | 0.080 |
Why?
| | Testicular Neoplasms | 2 | 2003 | 102 | 0.080 |
Why?
| | Burns | 1 | 2013 | 284 | 0.080 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2006 | 40 | 0.080 |
Why?
| | Genes, Reporter | 6 | 2013 | 266 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1046 | 0.070 |
Why?
| | Humans | 24 | 2019 | 128524 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2012 | 1141 | 0.070 |
Why?
| | Blotting, Western | 6 | 2013 | 1168 | 0.070 |
Why?
| | Protein Biosynthesis | 5 | 2003 | 397 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2019 | 4008 | 0.070 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2008 | 113 | 0.070 |
Why?
| | Peptides | 1 | 2013 | 909 | 0.070 |
Why?
| | Mouth Neoplasms | 1 | 2008 | 87 | 0.070 |
Why?
| | Alternative Splicing | 3 | 2011 | 218 | 0.070 |
Why?
| | Response Elements | 2 | 2005 | 89 | 0.070 |
Why?
| | Endoplasmic Reticulum | 2 | 2006 | 260 | 0.070 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2003 | 16 | 0.070 |
Why?
| | Cyclic AMP Response Element Modulator | 1 | 2006 | 2 | 0.070 |
Why?
| | Receptors, Androgen | 2 | 2005 | 143 | 0.060 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2006 | 102 | 0.060 |
Why?
| | Sperm Tail | 2 | 2002 | 5 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 2005 | 1284 | 0.060 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2005 | 7 | 0.060 |
Why?
| | Chromosome Mapping | 5 | 2011 | 505 | 0.060 |
Why?
| | Glycoside Hydrolases | 1 | 2005 | 33 | 0.060 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 4 | 2003 | 18 | 0.060 |
Why?
| | Gene Targeting | 3 | 2013 | 82 | 0.060 |
Why?
| | GATA1 Transcription Factor | 4 | 2003 | 18 | 0.060 |
Why?
| | Mice, Transgenic | 7 | 2005 | 2069 | 0.060 |
Why?
| | Multigene Family | 1 | 2005 | 198 | 0.060 |
Why?
| | Genes | 2 | 2003 | 226 | 0.060 |
Why?
| | GATA4 Transcription Factor | 1 | 2004 | 18 | 0.060 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 110 | 0.050 |
Why?
| | Olfactory Receptor Neurons | 1 | 2004 | 68 | 0.050 |
Why?
| | Follicle Stimulating Hormone | 2 | 2002 | 239 | 0.050 |
Why?
| | Mitochondrial ADP, ATP Translocases | 1 | 2003 | 2 | 0.050 |
Why?
| | Up-Regulation | 2 | 2004 | 826 | 0.050 |
Why?
| | DNA Damage | 1 | 2005 | 364 | 0.050 |
Why?
| | Female | 15 | 2018 | 68127 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1639 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2003 | 54 | 0.050 |
Why?
| | Sperm Count | 1 | 2002 | 17 | 0.050 |
Why?
| | Phylogeny | 3 | 2005 | 846 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 620 | 0.050 |
Why?
| | DNA, Circular | 1 | 2002 | 15 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2003 | 88 | 0.050 |
Why?
| | Procollagen | 1 | 2002 | 21 | 0.050 |
Why?
| | HeLa Cells | 4 | 2006 | 603 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2001 | 368 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 937 | 0.050 |
Why?
| | Prostatic Intraepithelial Neoplasia | 1 | 2002 | 12 | 0.050 |
Why?
| | Spermatocytes | 2 | 2005 | 7 | 0.050 |
Why?
| | Teratoma | 1 | 2003 | 103 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1333 | 0.050 |
Why?
| | Tissue Distribution | 4 | 2004 | 290 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2005 | 379 | 0.050 |
Why?
| | Molecular Chaperones | 2 | 2006 | 172 | 0.050 |
Why?
| | Immunomodulation | 1 | 2022 | 89 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2022 | 327 | 0.050 |
Why?
| | DNA | 5 | 2013 | 1392 | 0.050 |
Why?
| | Drosophila Proteins | 2 | 2001 | 187 | 0.050 |
Why?
| | Leydig Cells | 2 | 1998 | 13 | 0.050 |
Why?
| | Coenzyme A-Transferases | 1 | 2000 | 1 | 0.050 |
Why?
| | Intestine, Small | 1 | 2022 | 141 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1687 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2003 | 312 | 0.040 |
Why?
| | Androgen-Binding Protein | 1 | 2000 | 1 | 0.040 |
Why?
| | Ovary | 1 | 2002 | 214 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2002 | 293 | 0.040 |
Why?
| | Rats | 7 | 1999 | 5168 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 614 | 0.040 |
Why?
| | Collagen | 1 | 2002 | 429 | 0.040 |
Why?
| | Testicular Hormones | 1 | 1999 | 9 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2000 | 68 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 205 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-ets | 3 | 2008 | 53 | 0.040 |
Why?
| | Food Hypersensitivity | 1 | 2022 | 172 | 0.040 |
Why?
| | Binding Sites | 4 | 2006 | 1239 | 0.040 |
Why?
| | Ikaros Transcription Factor | 1 | 2019 | 21 | 0.040 |
Why?
| | Chromatin | 1 | 2003 | 478 | 0.040 |
Why?
| | Purpura | 1 | 2018 | 12 | 0.040 |
Why?
| | Protein Isoforms | 3 | 2011 | 375 | 0.040 |
Why?
| | Prostate | 1 | 2000 | 177 | 0.040 |
Why?
| | Sequence Analysis, DNA | 4 | 2005 | 773 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 79 | 0.040 |
Why?
| | Exanthema | 1 | 2018 | 70 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2002 | 567 | 0.040 |
Why?
| | Luciferases | 3 | 2005 | 147 | 0.040 |
Why?
| | Anemia, Sideroblastic | 1 | 1997 | 3 | 0.040 |
Why?
| | Testosterone | 1 | 2001 | 378 | 0.040 |
Why?
| | Transferrin | 1 | 1997 | 42 | 0.040 |
Why?
| | Cell Lineage | 1 | 1999 | 333 | 0.040 |
Why?
| | X Chromosome | 1 | 1997 | 51 | 0.040 |
Why?
| | Endopeptidases | 1 | 1997 | 83 | 0.030 |
Why?
| | Pyridoxine | 1 | 1997 | 32 | 0.030 |
Why?
| | Fever | 1 | 2018 | 301 | 0.030 |
Why?
| | Erythropoiesis | 1 | 1997 | 50 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 1998 | 188 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1997 | 87 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 2 | 1997 | 188 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1996 | 67 | 0.030 |
Why?
| | Fatigue | 1 | 2018 | 320 | 0.030 |
Why?
| | Introns | 4 | 1999 | 245 | 0.030 |
Why?
| | Point Mutation | 1 | 1997 | 224 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1999 | 371 | 0.030 |
Why?
| | Echocardiography | 1 | 2018 | 625 | 0.030 |
Why?
| | Crosses, Genetic | 2 | 2008 | 141 | 0.030 |
Why?
| | Microscopy, Fluorescence | 3 | 2000 | 402 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1416 | 0.030 |
Why?
| | Prostatic Neoplasms | 1 | 2002 | 1010 | 0.030 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 4 | 0.030 |
Why?
| | Sperm Motility | 2 | 2004 | 30 | 0.030 |
Why?
| | Syntaxin 1 | 1 | 2013 | 14 | 0.030 |
Why?
| | Clathrin | 1 | 2013 | 26 | 0.030 |
Why?
| | Tadalafil | 1 | 2013 | 7 | 0.030 |
Why?
| | Chemotactic Factors | 1 | 1993 | 54 | 0.030 |
Why?
| | Dimerization | 2 | 2006 | 188 | 0.030 |
Why?
| | TATA Box | 1 | 1993 | 24 | 0.030 |
Why?
| | Survival | 1 | 2013 | 39 | 0.030 |
Why?
| | Chemokines, CXC | 1 | 1993 | 68 | 0.030 |
Why?
| | Growth Substances | 1 | 1993 | 151 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1996 | 375 | 0.030 |
Why?
| | Biological Transport | 2 | 2005 | 394 | 0.030 |
Why?
| | Pain | 1 | 2018 | 756 | 0.030 |
Why?
| | Aging | 4 | 2008 | 1770 | 0.030 |
Why?
| | Cricetinae | 2 | 2005 | 275 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1043 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 308 | 0.020 |
Why?
| | Apoptosis | 3 | 2006 | 2437 | 0.020 |
Why?
| | Rats, Wistar | 1 | 1993 | 398 | 0.020 |
Why?
| | Anemia | 1 | 1993 | 156 | 0.020 |
Why?
| | Species Specificity | 2 | 2005 | 567 | 0.020 |
Why?
| | Random Amplified Polymorphic DNA Technique | 1 | 2011 | 3 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2013 | 462 | 0.020 |
Why?
| | Protein Structure, Tertiary | 2 | 2005 | 836 | 0.020 |
Why?
| | Blotting, Southern | 2 | 2001 | 68 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 310 | 0.020 |
Why?
| | Organ Specificity | 2 | 2002 | 291 | 0.020 |
Why?
| | Cell Fractionation | 2 | 2000 | 56 | 0.020 |
Why?
| | Cell Cycle | 2 | 2005 | 581 | 0.020 |
Why?
| | Gestational Age | 1 | 1993 | 862 | 0.020 |
Why?
| | Mice, Inbred Strains | 2 | 2001 | 402 | 0.020 |
Why?
| | DNA Primers | 2 | 2003 | 510 | 0.020 |
Why?
| | Transcriptional Activation | 2 | 2005 | 355 | 0.020 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1229 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2011 | 681 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 266 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 440 | 0.020 |
Why?
| | Animals, Newborn | 2 | 2003 | 805 | 0.020 |
Why?
| | Cell Movement | 2 | 2004 | 937 | 0.020 |
Why?
| | Neutrophils | 1 | 1993 | 1188 | 0.020 |
Why?
| | Time Factors | 3 | 2004 | 6503 | 0.020 |
Why?
| | Fertility | 1 | 2008 | 162 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1998 | 251 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2001 | 425 | 0.020 |
Why?
| | Models, Genetic | 2 | 2000 | 590 | 0.020 |
Why?
| | Protein Binding | 2 | 2005 | 2097 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3366 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 480 | 0.020 |
Why?
| | Histone Chaperones | 1 | 2006 | 15 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2006 | 417 | 0.020 |
Why?
| | Cycloheximide | 1 | 2005 | 55 | 0.020 |
Why?
| | Bone Marrow | 2 | 1997 | 267 | 0.020 |
Why?
| | Leucine Zippers | 1 | 2005 | 16 | 0.020 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2005 | 14 | 0.020 |
Why?
| | Hydroxyurea | 1 | 2005 | 31 | 0.020 |
Why?
| | Gene Components | 1 | 2005 | 5 | 0.020 |
Why?
| | Neurospora crassa | 1 | 2005 | 17 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2005 | 37 | 0.020 |
Why?
| | Caspases | 1 | 2006 | 242 | 0.020 |
Why?
| | Cricetulus | 1 | 2005 | 104 | 0.020 |
Why?
| | Half-Life | 1 | 2005 | 144 | 0.020 |
Why?
| | Histidine | 1 | 2005 | 58 | 0.020 |
Why?
| | Metribolone | 1 | 2005 | 5 | 0.020 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2005 | 36 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 83 | 0.010 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2005 | 25 | 0.010 |
Why?
| | Adherens Junctions | 1 | 2005 | 26 | 0.010 |
Why?
| | Glycosylation | 1 | 2005 | 146 | 0.010 |
Why?
| | Sperm-Ovum Interactions | 1 | 2004 | 12 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2005 | 157 | 0.010 |
Why?
| | Flagella | 1 | 2004 | 19 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2005 | 179 | 0.010 |
Why?
| | Child, Preschool | 1 | 2019 | 10373 | 0.010 |
Why?
| | Fertilization | 1 | 2004 | 42 | 0.010 |
Why?
| | RNA | 2 | 2001 | 881 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 330 | 0.010 |
Why?
| | Mitochondria | 2 | 2003 | 844 | 0.010 |
Why?
| | Receptors, Odorant | 1 | 2004 | 39 | 0.010 |
Why?
| | Chemotaxis | 1 | 2004 | 130 | 0.010 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2005 | 153 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 230 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2005 | 311 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 43 | 0.010 |
Why?
| | DNA Replication | 1 | 2005 | 224 | 0.010 |
Why?
| | Ornithine Carbamoyltransferase | 1 | 2003 | 2 | 0.010 |
Why?
| | Protamines | 1 | 2003 | 7 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3943 | 0.010 |
Why?
| | Models, Chemical | 1 | 2004 | 262 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 345 | 0.010 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2002 | 5 | 0.010 |
Why?
| | Seminal Plasma Proteins | 1 | 2002 | 10 | 0.010 |
Why?
| | Restriction Mapping | 1 | 2002 | 74 | 0.010 |
Why?
| | Genome | 1 | 2005 | 277 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2003 | 258 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 384 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2005 | 450 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 142 | 0.010 |
Why?
| | Base Pairing | 1 | 2002 | 61 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2002 | 80 | 0.010 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2002 | 17 | 0.010 |
Why?
| | Isoenzymes | 1 | 2003 | 304 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 226 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 2002 | 77 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 580 | 0.010 |
Why?
| | COS Cells | 1 | 2002 | 184 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 179 | 0.010 |
Why?
| | RNA-Induced Silencing Complex | 1 | 2001 | 7 | 0.010 |
Why?
| | PTEN Phosphohydrolase | 1 | 2003 | 157 | 0.010 |
Why?
| | Argonaute Proteins | 1 | 2001 | 28 | 0.010 |
Why?
| | Flutamide | 1 | 2001 | 5 | 0.010 |
Why?
| | Prostatic Hyperplasia | 1 | 2002 | 42 | 0.010 |
Why?
| | Dipeptides | 1 | 2001 | 48 | 0.010 |
Why?
| | Androgen Receptor Antagonists | 1 | 2001 | 36 | 0.010 |
Why?
| | Mice, Nude | 1 | 2003 | 682 | 0.010 |
Why?
| | Escherichia coli | 1 | 2005 | 770 | 0.010 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2000 | 6 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2000 | 93 | 0.010 |
Why?
| | Androgen Antagonists | 1 | 2001 | 78 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2000 | 149 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 2001 | 178 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1681 | 0.010 |
Why?
| | Stromal Cells | 1 | 2001 | 105 | 0.010 |
Why?
| | Signal Transduction | 2 | 2005 | 4829 | 0.010 |
Why?
| | Phospholipid Transfer Proteins | 1 | 2000 | 10 | 0.010 |
Why?
| | Pancreas | 1 | 2003 | 307 | 0.010 |
Why?
| | Sequence Homology | 1 | 2000 | 40 | 0.010 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2000 | 3 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 30 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2001 | 313 | 0.010 |
Why?
| | Ornithine Decarboxylase | 1 | 2000 | 9 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2008 | 3160 | 0.010 |
Why?
| | Frameshifting, Ribosomal | 1 | 2000 | 6 | 0.010 |
Why?
| | Pregnancy | 1 | 1993 | 6297 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 1943 | 0.010 |
Why?
| | Polyamines | 1 | 2000 | 39 | 0.010 |
Why?
| | CHO Cells | 1 | 2000 | 150 | 0.010 |
Why?
| | Mutation | 2 | 2002 | 3692 | 0.010 |
Why?
| | CapZ Actin Capping Protein | 1 | 1999 | 2 | 0.010 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2001 | 207 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2000 | 116 | 0.010 |
Why?
| | Gonads | 1 | 1999 | 23 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 685 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 20213 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 357 | 0.010 |
Why?
| | Child | 1 | 2019 | 20721 | 0.010 |
Why?
| | Inbreeding | 1 | 1999 | 17 | 0.010 |
Why?
| | CpG Islands | 1 | 1999 | 152 | 0.010 |
Why?
| | Stem Cell Transplantation | 1 | 2000 | 164 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1178 | 0.010 |
Why?
| | Selenoprotein P | 1 | 1998 | 3 | 0.010 |
Why?
| | Mesylates | 1 | 1998 | 7 | 0.010 |
Why?
| | Selenoproteins | 1 | 1998 | 7 | 0.010 |
Why?
| | Rabbits | 1 | 1999 | 761 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1997 | 8 | 0.010 |
Why?
| | Receptors, LH | 1 | 1997 | 9 | 0.010 |
Why?
| | Kidney | 1 | 2005 | 1305 | 0.010 |
Why?
| | Cathepsin L | 1 | 1997 | 9 | 0.010 |
Why?
| | Clusterin | 1 | 1997 | 10 | 0.010 |
Why?
| | Fibroblasts | 1 | 2003 | 939 | 0.010 |
Why?
| | Cathepsins | 1 | 1997 | 24 | 0.010 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2000 | 325 | 0.010 |
Why?
| | Erythroid Precursor Cells | 1 | 1997 | 4 | 0.010 |
Why?
| | Yolk Sac | 1 | 1997 | 5 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 1997 | 67 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 1999 | 217 | 0.010 |
Why?
| | Aspartic Acid | 1 | 1997 | 79 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1997 | 94 | 0.010 |
Why?
| | Valine | 1 | 1997 | 74 | 0.010 |
Why?
| | Protein Phosphatase 2C | 1 | 1996 | 15 | 0.010 |
Why?
| | Protein Phosphatase 2 | 1 | 1996 | 37 | 0.010 |
Why?
| | Genetic Markers | 1 | 1997 | 339 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3050 | 0.010 |
Why?
| | Conserved Sequence | 1 | 1997 | 228 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 731 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1996 | 367 | 0.010 |
Why?
| | Glycoproteins | 1 | 1997 | 337 | 0.010 |
Why?
| | Models, Biological | 1 | 2002 | 1693 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1616 | 0.010 |
Why?
| | Antioxidants | 1 | 1998 | 543 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1997 | 1288 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2000 | 1036 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1993 | 73 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1997 | 3023 | 0.010 |
Why?
| | Aged | 1 | 2002 | 21971 | 0.000 |
Why?
| | Middle Aged | 1 | 2002 | 30893 | 0.000 |
Why?
|
|
Yomogida's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|